Four inmates at 201 Poplar are now dead. An investigation is underway to determine the cause of death for the most recent ...

Multiple sclerosis, often shortened to 'MS', is a long-lasting chronic disease of the central nervous system. There is ...

Known for her expertise on midcentury modernism and love of Southwestern colors, she also helped create an annual event ...

Lebanon’s new prime minister on Saturday formed the country’s first full-fledged government since 2022. President Joseph Aoun ...

Two new medications, called lecanemab and donanemab, have shown success in clinical trials in slowing down Alzheimer’s disease. These are known as disease-modifying treatments and have been licensed ...

The Justice Department says it won't pull out of the Supreme Court case over Tennessee's ban on gender treatments for ...

Stock investors may look back at 2025 as the year of the takeover - one that delivered sizeable gains. "It's going to be a big year," Calamos Investments senior portfolio manager Brandon Nelson ...

A study by the United Arab Emirates University aimed to develop and validate a sensitive method for the determination of six ...

Alumis is also developing another tyrosine kinase 2 blocker, A-005, for neuroinflammatory and neurodegenerative conditions ...

The two biotechs, which have lost most of their share value following lucrative IPOs, are combining in a deal that leaves the ...

Alumis Inc. will merge with a Southern California drug developer in a deal that extends the combined companies' cash into ...